Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Gralla

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Seminars in Oncology|March 15, 2002
New agents, new treatment, and antiemetic therapyRichard J Gralla
Annals of Palliative Medicine|September 6, 2018
Radiation therapy and delayed emesisRichard J Gralla
The Oncologist|December 24, 2004
Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of lifeRichard J Gralla
The Lancet. Oncology|March 16, 2015
Anti-emetics in paediatric patients receiving chemotherapyRichard J Gralla
Cancer|October 10, 2015
Quality-of-life evaluation in cancer: The past and the futureRichard J Gralla
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Coming of age for monitoring quality of life and patient-reported outcomesRichard J Gralla
Nature Reviews. Clinical Oncology|October 17, 2012
Palliative care: Aprepitant and control of emesis induced by 5-day chemotherapyRichard J Gralla
Journal of Oncology Practice|February 17, 2018
Progress in the Control of Chemotherapy-Induced Emesis: New Agents and New StudiesRichard J Gralla, Harry Raftopoulos
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2007
Interpreting clinical trials in lung cancer: impact of methodology and endpointsRichard J Gralla, Frank Griesinger
Lung Cancer (Amsterdam, Netherlands)|February 9, 2005
Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapyRichard J Gralla, Nick Thatcher
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Seminars in Oncology|March 15, 2002
New agents, new treatment, and antiemetic therapyRichard J Gralla
Annals of Palliative Medicine|September 6, 2018
Radiation therapy and delayed emesisRichard J Gralla
The Oncologist|December 24, 2004
Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of lifeRichard J Gralla
The Lancet. Oncology|March 16, 2015
Anti-emetics in paediatric patients receiving chemotherapyRichard J Gralla
Cancer|October 10, 2015
Quality-of-life evaluation in cancer: The past and the futureRichard J Gralla
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Coming of age for monitoring quality of life and patient-reported outcomesRichard J Gralla
Nature Reviews. Clinical Oncology|October 17, 2012
Palliative care: Aprepitant and control of emesis induced by 5-day chemotherapyRichard J Gralla
Journal of Oncology Practice|February 17, 2018
Progress in the Control of Chemotherapy-Induced Emesis: New Agents and New StudiesRichard J Gralla, Harry Raftopoulos
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2007
Interpreting clinical trials in lung cancer: impact of methodology and endpointsRichard J Gralla, Frank Griesinger
Lung Cancer (Amsterdam, Netherlands)|February 9, 2005
Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapyRichard J Gralla, Nick Thatcher
Pageof 7